Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

NCT03426761 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Bone Infection
Osteomyelitis
Septic Arthritis
Joint Infection
Prosthetic Joint Infection

Interventions

DRUG: Dalbavancin
DRUG: Vancomycin

Sponsor

Infectious Diseases Physicians, Inc.

Collaborators

[object Object]